Classification of mutations at the HLA-A locus by use of the polymerase chain reaction
β Scribed by Grant Joseph; Scott Grist; Frank Firgaira; David Turner; Alec Morley
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 432 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0893-6692
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
We investigated whether the polymerase chain reaction (PCR) could be used to determine the mechanism of mutation in lymphocyte clones mutated at the HLAβA locus. Three polymorphisms, at Factor XIIIA, D6S109, and intron 3 of the HLAβA gene, were used to study a series of clones previously characterised by Southern blotting (SB) at multiple loci on chromosome 6. For detection of loss of heterozygosity, the results of PCR and SB were concordant in 140 of 141 clones when polymorphism in the Factor XIIIA region was studied and in 144 of 145 clones when polymorphism in the HLAβA gene was studied. For classification of the mechanism of mutation, PCR and SB gave the same result in 88 of 92 clones (96%) when a combination of the HLAβA and Factor XIIIA polymorphisms was used and in 46 of 47 clones (98%) when a combination of the HLAβA and D6S109 polymorphisms was used. The results indicate that PCR provides a simple and reliable method for categorising mutations at the HLAβA locus as arising from mitotic recombination, deletion, or from presumptive minor changes within the gene. Rare events such as gene conversion, nondisjunction, or large deletions extending to the telomere will be misclassified. However, such events are rare for mutations at this locus. Β© 1993 WileyβLiss, Inc.
π SIMILAR VOLUMES
We have studied 3 I male germ cell tumors (GCTs) for probable mutations in codons 12, 13, and 6 I of HRAS, KRAS, and NRAS oncogenes using the polymerase chain reaction. Twenty of the thirty-one tumors exhibited NRAS gene mutations, 14 in codon 6 I, and six in codon 12, whereas no mutations were dete
## Communicated by Stylianos E. Antonarakis The allele-specific PCR approach has been modified by introducing a second mismatch at the 3'penultimate link of the primer and used to identify the sickle cell anemia mutation (A + T transversion in the sixth codon of the human P-globin gene causing Glu
Skeletal muscle tissue contains polymerase chain reaction (PCR) inhibitors that are coextracted by conventional nucleic acid extraction procedures. Myoglobin, a heme-containing molecule, was shown to act as a potent Thermus aquaticus DNA polymerase inhibitor and is likely to be involved in muscle ti